Melt-extrusion multiparticulates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6335033
SERIAL NO

09358828

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an optional water-insoluble binder is disclosed. The particles have a length of from about 0.1 to about 12 mm and can be of varying diameters and each unit dose provides a release of therapeutically active agents over at least about 8 hours. Methods of preparing the unit doses as well as extrusion processes and methods of treatment are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • PURDUE PHARMA L.P.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chasin, Mark Manalapan, NJ 116 12711
Huang, Hua-Pin Englewood Cliffs, NJ 64 4096
Oshlack, Benjamin New York, NY 246 21083

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation